πŸ‡ΊπŸ‡Έ FDA
Patent

US 10562953

GPR156 variants and uses thereof

granted A61PA61P25/24

Quick answer

US patent 10562953 (GPR156 variants and uses thereof) held by REGENERON PHARMACEUTICALS, INC. expires Mon Feb 13 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
REGENERON PHARMACEUTICALS, INC.
Grant date
Tue Feb 18 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 13 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61P, A61P25/24